title: Circulating forms of the b-type natriuretic peptide prohormone: pathophysiologic and clinical considerations.
abstract: Recent studies reported that many different biochemical forms of B-type-related peptides circulate in human blood. In particular, a significant amount of the prohormone peptide (i.e., proBNP108) can be detected in plasma of patients with heart failure. These data indicate that the posttranslational maturation processing of the B-type natriuretic peptide (BNP) precursor may not be efficient in heart failure. The aim of this chapter is to describe the biochemical pathways of proBNP108 maturation and to discuss the pathophysiological relevance of alteration of the posttranslational maturation mechanisms in heart failure. An impaired cardiac endocrine function was proposed to explain the altered electrolyte and fluid homeostasis occurring in chronic heart failure. Recent studies demonstrated that a great part of BNPs assayed by immunoassay methods in healthy subjects and in patients with cardiovascular disease is devoid of biological activity. These findings suggest that an alteration in posttranslational maturation of BNP precursor may promote the resistance to biological action of BNP in patients with heart failure at a prereceptor level. These studies also open a new and more complex scenario regarding the circulating BNPs. The active hormone (i.e., BNP1-32) may be produced even in vivo from the circulating precursor proBNP108 by plasma enzyme degradation, such as the soluble form of corin, possibly able to process the circulating intact precursor of natriuretic hormones. As a future perspective, the simultaneous measurement of the proBNP1-108 and the active peptide BNP1-32 with more specific methods could allow a more accurate estimation of both production/secretion of B-type-related peptides from cardiomyocytes and the true activity of the cardiac endocrine function.
authors.affiliation: Fondazione G. Monasterio, CNR-Regione Toscana, Pisa, Italy. aldo.clerico@sssup.it
authors.forename: Aldo
authors.initials: A
authors.lastname: Clerico
authors.forename: Simona
authors.initials: S
authors.lastname: Vittorini
authors.forename: Claudio
authors.initials: C
authors.lastname: Passino
mesh_terms: D000818:Animals; D006321:Heart / Q000503:physiopathology; D006333:Heart Failure / Q000097:blood* / Q000378:metabolism* / Q000503:physiopathology; D006801:Humans; D007118:Immunoassay / Q000379:methods; D032383:Myocytes, Cardiac / Q000378:metabolism / Q000473:pathology; D020097:Natriuretic Peptide, Brain / Q000097:blood* / Q000378:metabolism*; D011499:Protein Processing, Post-Translational
chemical_list: D020097:Natriuretic Peptide, Brain